MedTrace Logo

Emergency Department Management of Tobacco Use Disorder

NCT06350175 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2025-01-02

No results posted yet for this study

Summary

The objective of this study is to determine the effectiveness of ED initiated NRT on tobacco cessation point abstinence rates as reported by patients at 2 weeks and 1 month post randomization, and continued abstinence rates at 3 months compared to standard of care therapy.

Conditions

  • Tobacco Use Disorder
  • Tobacco Use Cessation

Interventions

COMBINATION_PRODUCT

Nicotine Replacement Therapy Agent

The NRT Agents-- 21mg nicotine patches (x14) and 2 mg nicotine lozenges (\~210).

OTHER

West Virginia Quit Line

Instructional Pamphlets and contact information for the WV QL. A telehealth line set up to assist people of WV to quit smoking.

Sponsors & Collaborators

  • West Virginia University

    lead OTHER

Principal Investigators

  • Bradley End · West Virginia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-31
Primary Completion
2025-03-31
Completion
2025-06-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06350175 on ClinicalTrials.gov